相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells
I. V. Fedorenko et al.
ONCOGENE (2016)
mTORC1 Activation Blocks BrafV600E-Induced Growth Arrest but Is Insufficient for Melanoma Formation
William Damsky et al.
CANCER CELL (2015)
Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling
Eishu Hirata et al.
CANCER CELL (2015)
UPR, autophagy, and mitochondria crosstalk underlies the ER stress response
Daniela Senft et al.
TRENDS IN BIOCHEMICAL SCIENCES (2015)
Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids
Teresa Peart et al.
ONCOTARGET (2015)
HIGD1A Regulates Oxygen Consumption, ROS Production, and AMPK Activity during Glucose Deprivation to Modulate Cell Survival and Tumor Growth
Kurosh Ameri et al.
CELL REPORTS (2015)
Oncogenic BRAF induces chronic ER stress condition resulting in increased basal autophagy and apoptotic resistance of cutaneous melanoma
M. Corazzari et al.
CELL DEATH AND DIFFERENTIATION (2015)
PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells
Natalie C. Schlegel et al.
EXPERIMENTAL DERMATOLOGY (2015)
Tumor heterogeneity and plasticity as elusive drivers for resistance to MAPK pathway inhibition in melanoma
A. Roesch
ONCOGENE (2015)
Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2
Patrizia Borsotti et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
Nicolas Acquavella et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Metastasis prevention by targeting the dormant niche
Cyrus M. Ghajar
NATURE REVIEWS CANCER (2015)
Immunosurveillance by Antiangiogenesis: Tumor Growth Arrest by T Cell-Derived Thrombospondin-1
Keri L. Schadler et al.
CANCER RESEARCH (2014)
Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression
G. Denecker et al.
CELL DEATH AND DIFFERENTIATION (2014)
New insights into cancer immunoediting and its three component phases elimination, equilibrium and escape
Deepak Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2
Chelsea Ma et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2014)
IL-2: The First Effective Immunotherapy for Human Cancer
Steven A. Rosenberg
JOURNAL OF IMMUNOLOGY (2014)
Oncogenic Activation of MEK/ERK Primes Melanoma Cells for Adaptation to Endoplasmic Reticulum Stress
Amanda Croft et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
TGF-β: Duality of Function Between Tumor Prevention and Carcinogenesis
Daniel R. Principe et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study
Pippa G. Corrie et al.
LANCET ONCOLOGY (2014)
Setting the bar for adjuvant treatment of melanoma
Vernon K. Sondak et al.
LANCET ONCOLOGY (2014)
Direct measurement of local oxygen concentration in the bone marrow of live animals
Joel A. Spencer et al.
NATURE (2014)
Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression
Janna K. Mouw et al.
NATURE MEDICINE (2014)
A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF
V. Borgdorff et al.
ONCOGENE (2014)
Vascular channels formed by subpopulations of PECAM1+ melanoma cells
James M. Dunleavey et al.
NATURE COMMUNICATIONS (2014)
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Judith Mueller et al.
NATURE COMMUNICATIONS (2014)
A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
David J. Konieczkowski et al.
CANCER DISCOVERY (2014)
Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma
Aparna Jayachandran et al.
ONCOTARGET (2014)
Axl as a mediator of cellular growth and survival
Haley Axelrod et al.
ONCOTARGET (2014)
Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade
Zachary A. Cooper et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Evidence of synergy with combined BRAF-targeted therapy and immune checkpoint blockade for metastatic melanoma
Zachary A. Cooper et al.
ONCOIMMUNOLOGY (2014)
The impact of the immune system on tumor: angiogenesis and vascular remodeling
Christian Stockmann et al.
FRONTIERS IN ONCOLOGY (2014)
Crosstalk of oncogenic signaling pathways during epithelial-mesenchymal transition
Stephan Lindsey et al.
FRONTIERS IN ONCOLOGY (2014)
Mechanisms of disseminated cancer cell dormancy: an awakening field
Maria Soledad Sosa et al.
NATURE REVIEWS CANCER (2014)
Insights into the Transforming Growth Factor-β Signaling Pathway in Cutaneous Melanoma
Carole Yolande Perrot et al.
ANNALS OF DERMATOLOGY (2013)
The pre-metastatic niche: finding common ground
Jaclyn Sceneay et al.
CANCER AND METASTASIS REVIEWS (2013)
Directed Phenotype Switching as an Effective Antimelanoma Strategy
Magali Saez-Ayala et al.
CANCER CELL (2013)
A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma
Julie Caramel et al.
CANCER CELL (2013)
The Dormancy Dilemma: Quiescence versus Balanced Proliferation
Alan Wells et al.
CANCER RESEARCH (2013)
LOX-Mediated Collagen Crosslinking Is Responsible for Fibrosis-Enhanced Metastasis (Publication with Expression of Concern. See vol. 79, pg. 5124, 2019)
Thomas R. Cox et al.
CANCER RESEARCH (2013)
Mechanisms Governing Metastatic Dormancy and Reactivation
Filippo G. Giancotti
CELL (2013)
Local expression of interleukin-2 by B16 melanoma cells results in decreased tumour growth and long-term tumour dormancy
Scott A. Gerber et al.
IMMUNOLOGY (2013)
Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment
Brent A. Hanks et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Hypoxia Contributes to Melanoma Heterogeneity by Triggering HIF1α-Dependent Phenotype Switching
Daniel S. Widmer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Late Recurrence in Melanoma: Clinical Implications of Lost Dormancy
Mark B. Faries et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2013)
T-helper-1-cell cytokines drive cancer into senescence
Heidi Braumueller et al.
NATURE (2013)
TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling
Paloma Bragado et al.
NATURE CELL BIOLOGY (2013)
The perivascular niche regulates breast tumour dormancy
Cyrus M. Ghajar et al.
NATURE CELL BIOLOGY (2013)
Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion
J. Ferguson et al.
ONCOGENE (2013)
The receptor tyrosine kinase Ax1 is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target
J. D. Paccez et al.
ONCOGENE (2013)
Emerging molecular targets in melanoma invasion and metastasis
Jose L. Orgaz et al.
PIGMENT CELL & MELANOMA RESEARCH (2013)
Could pericytic mimicry represent another type of melanoma cell plasticity with embryonic properties?
Claire Lugassy et al.
PIGMENT CELL & MELANOMA RESEARCH (2013)
GAS6 Receptor Status Is Associated with Dormancy and Bone Metastatic Tumor Formation
Russell S. Taichman et al.
PLOS ONE (2013)
Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
Stefani Spranger et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
The PI3K/AKT Signaling Pathway Controls the Quiescence of the Low-Rhodamine123-Retention Cell Compartment Enriched for Melanoma Stem Cell Activity
Yasmine Touil et al.
STEM CELLS (2013)
Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2
Michael P. O'Connell et al.
CANCER DISCOVERY (2013)
TBK1 Regulates Prostate Cancer Dormancy through mTOR Inhibition
Jin Koo Kim et al.
NEOPLASIA (2013)
The prostate cancer bone marrow niche: more than just 'fertile soil'
Elisabeth A. Pedersen et al.
ASIAN JOURNAL OF ANDROLOGY (2012)
LKB1/STK11 Inactivation Leads to Expansion of a Prometastatic Tumor Subpopulation in Melanoma
Wenjin Liu et al.
CANCER CELL (2012)
The BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic Sites
Hua Gao et al.
CELL (2012)
PHF19 and Akt control the switch between proliferative and invasive states in melanoma
Stephanie Ghislin et al.
CELL CYCLE (2012)
Staying alive Metabolic adaptations to quiescence
James R. Valcourt et al.
CELL CYCLE (2012)
The Role of Angiogenesis Inhibitors in the Management of Melanoma
Kamarul Ahmad Zaki et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
BEAM: A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Melanoma
Kevin B. Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Hypoxia Stabilizes GAS6/Axl Signaling in Metastatic Prostate Cancer
Anjali Mishra et al.
MOLECULAR CANCER RESEARCH (2012)
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
Jennifer Landsberg et al.
NATURE (2012)
Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells
Y. Cheli et al.
ONCOGENE (2012)
Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer
Oddbjorn Straume et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Metformin Accelerates the Growth of BRAFV600E-Driven Melanoma by Upregulating VEGF-A
Matthew J. Martin et al.
CANCER DISCOVERY (2012)
TGF-beta-RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases
Khalid S. Mohammad et al.
CANCER RESEARCH (2011)
Thrombospondin-1 Triggers Cell Migration and Development of Advanced Prostate Tumors
Virginie Firlej et al.
CANCER RESEARCH (2011)
In Vivo Identification of Tumor-Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma
Florian A. Karreth et al.
CELL (2011)
ERK1/2 and p38α/β Signaling in Tumor Cell Quiescence: Opportunities to Control Dormant Residual Disease
Maria Soledad Sosa et al.
CLINICAL CANCER RESEARCH (2011)
The Two Faces of Interferon-γ in Cancer
M. Raza Zaidi et al.
CLINICAL CANCER RESEARCH (2011)
Matrix Stiffness Modulates Proliferation, Chemotherapeutic Response, and Dormancy in Hepatocellular Carcinoma Cells
Joerg Schrader et al.
HEPATOLOGY (2011)
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
Yusuke Shiozawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
Aya Kobayashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Interferon-γ links ultraviolet radiation to melanomagenesis in mice
M. Raza Zaidi et al.
NATURE (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2011)
Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny
Y. Cheli et al.
ONCOGENE (2011)
GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells
Delphine Javelaud et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
The role of mitogen- and stress-activated protein kinase pathways in melanoma
Pablo Lopez-Bergami
PIGMENT CELL & MELANOMA RESEARCH (2011)
Mechanisms of breast cancer bone metastasis
Yunfei Zhang et al.
CANCER LETTERS (2010)
Metastatic Growth from Dormant Cells Induced by a Col-I-Enriched Fibrotic Environment
Dalit Barkan et al.
CANCER RESEARCH (2010)
GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche
Yusuke Shiozawa et al.
EXPERIMENTAL HEMATOLOGY (2010)
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
Jo Eyles et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Discovery of a Novel Unfolded Protein Response Phenotype of Cancer Stem/Progenitor Cells from the Bone Marrow of Breast Cancer Patients
Kai Bartkowiak et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Late recurrence (10 years or more) of malignant melanoma in south-east Germany (Saxony) A single-centre analysis of 1881 patients with a follow-up of 10 years or more
G. Hansel et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Transmission of donor melanoma by organ transplantation
Dirk C. Strauss et al.
LANCET ONCOLOGY (2010)
Real-time imaging reveals the single steps of brain metastasis formation
Yvonne Kienast et al.
NATURE MEDICINE (2010)
Dormancy of metastatic melanoma
Liliana Ossowski et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
Cancer stem cells versus phenotype-switching in melanoma
Keith S. Hoek et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
Integrins and Extracellular Matrix in Mechanotransduction
Martin Alexander Schwartz
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche
Yusuke Shiozawa et al.
NEOPLASIA (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Transcriptional Switch of Dormant Tumors to Fast-Growing Angiogenic Phenotype
Nava Almog et al.
CANCER RESEARCH (2009)
Intravital Imaging Reveals Transient Changes in Pigment Production and Brn2 Expression during Metastatic Melanoma Dissemination
Sophie Pinner et al.
CANCER RESEARCH (2009)
Oncogenic B-RAF Negatively Regulates the Tumor Suppressor LKB1 to Promote Melanoma Cell Proliferation
Bin Zheng et al.
MOLECULAR CELL (2009)
BrafV600E cooperates with Pten loss to induce metastatic melanoma
David Dankort et al.
NATURE GENETICS (2009)
Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation
Yeriel Estrada et al.
PIGMENT CELL & MELANOMA RESEARCH (2009)
Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs
Tsukasa Shibue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
TNFR1 signaling and IFN-γ signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis
Nele Mueller-Hermelink et al.
CANCER CELL (2008)
In vivo switching of human melanoma cells between proliferative and invasive states
Keith S. Hoek et al.
CANCER RESEARCH (2008)
Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton
Dalit Barkan et al.
CANCER RESEARCH (2008)
Annexin II/Annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer
Yusuke Shiozawa et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases
Renee Lengagne et al.
JOURNAL OF IMMUNOLOGY (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
Models, mechanisms and clinical evidence for cancer dormancy
Julio A. Aguirre-Ghiso
NATURE REVIEWS CANCER (2007)
Inhibition of MEK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis
Chen Chen Jiang et al.
CANCER RESEARCH (2007)
The cyclin-dependent kinase inhibitors p15INK4B and p21CIP1 are critical regulators of fibrillar collagen-induced tumor cell cycle arrest
Steven J. Wall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanoma
Kimberly A. Varker et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis
Delphine Javelaud et al.
CANCER RESEARCH (2007)
IFN-γ mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy
Vanessa Berner et al.
NATURE MEDICINE (2007)
The energy sensing LKB1-AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis
Jiyong Liang et al.
NATURE CELL BIOLOGY (2007)
Mitf regulation of Dia1 controls melanoma proliferation and invasiveness
Suzanne Carreira et al.
GENES & DEVELOPMENT (2006)
The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β
Ksenya Shchors et al.
GENES & DEVELOPMENT (2006)
A model of human tumor dormancy: An angiogenic switch from the nonangiogenic phenotype
GN Naumov et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi
Pablo Uribe et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Discoidin domain receptor 2 mediates tumor cell cycle arrest induced by fibrillar collagen
SJ Wall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor
PP Sainaghi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors
S North et al.
CANCER LETTERS (2005)
In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis
A Saudemont et al.
BLOOD (2004)
EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma
D Liu et al.
CANCER CELL (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
Thrombospondin-1-mediated metastasis suppression by the primary tumor human melanoma xenografts
EK Rofstad et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Heterogeneity of angiogenic activity in a human liposarcoma: A proposed mechanism for no take of human tumors in mice
EG Achilles et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Incidence and sites of distant metastases from head and neck cancer
A Ferlito et al.
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES (2001)
Hematopoietic progenitor cells grow on 3T3 fibroblast monolyers that overexpress growth arrest-specific gene-6 (GAS6)
SP Dormady et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1
P Henriet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
